# OnCo record nct02730299 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02730299/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02730299", "NCT02730299" ;
  schema:name "Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS"@en ;
  schema:description "A phase 3 trial of Omidubicel in Acute lymphoblastic leukaemia and Leukaemia, run by Gamida Cell ltd, completed."@en ;
  schema:url <https://onco.cc/trials/nct02730299/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02730299> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/leukaemia/> ;
  onco:drugs <https://onco.cc/drugs/omidubicel/> ;
  onco:companies <https://onco.cc/companies/gamida-cell/> .
